Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.32
-0.01-0.75%
Last update: Jun 10, 10:59 AM
Artelo Biosciences Inc Analyst Ratings
ARTLNASDAQ
Artelo Biosciences Analyst Ratings and Price Targets | NASDAQ:ARTL | Benzinga
Artelo Biosciences Inc has a consensus price target of $5.5 based on the ratings of 4 analysts. The high is $6 issued by EF Hutton on October 1, 2024. The low is $5 issued by HC Wainwright & Co. on March 4, 2025. The 3 most-recent analyst ratings were released by D. Boral Capital on August 26, 2025, August 18, 2025, and August 6, 2025, respectively. With an average price target of $18 between D. Boral Capital, there's an implied 1263.64% upside for Artelo Biosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
EF Hutton
1calculated from analyst ratings
Analyst Ratings for Artelo Biosciences
Loading calendar...
FAQ
What is the target price for Artelo Biosciences (ARTL) stock?
The latest price target for Artelo Biosciences (NASDAQ:ARTL) was reported by Maxim Group on November 19, 2025. The analyst firm set a price target for $0.00 expecting ARTL to fall to within 12 months (a possible -100.00% downside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Artelo Biosciences (ARTL)?
The latest analyst rating for Artelo Biosciences (NASDAQ:ARTL) was provided by Maxim Group, and Artelo Biosciences downgraded their hold rating.
When was the last upgrade for Artelo Biosciences (ARTL)?
The last upgrade for Artelo Biosciences Inc happened on July 8, 2025 when D. Boral Capital raised their price target to $20. D. Boral Capital previously had a hold for Artelo Biosciences Inc.
When was the last downgrade for Artelo Biosciences (ARTL)?
The last downgrade for Artelo Biosciences Inc happened on November 19, 2025 when Maxim Group changed their price target from N/A to N/A for Artelo Biosciences Inc.
When is the next analyst rating going to be posted or updated for Artelo Biosciences (ARTL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Artelo Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Artelo Biosciences was filed on November 19, 2025 so you should expect the next rating to be made available sometime around November 19, 2026.
Is the Analyst Rating Artelo Biosciences (ARTL) correct?
While ratings are subjective and will change, the latest Artelo Biosciences (ARTL) rating was a downgraded with a price target of $0.00 to $0.00. The current price Artelo Biosciences (ARTL) is trading at is $1.32, which is out of the analyst’s predicted range.
